This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Leonard T. Kurland, MD, DrPH
Department of Medical Statistics and Epidemiology Mayo Clinic and Mayo Foundation Rochester, MN 55905

W. C. Wiederholt, MD, MPH
Department of Neurosciences School of Medicine University of California, San Diego LaJolla, CA 92093

Arch Neurol. 1986;43(10):979-981.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Since we initiated the studies that have now led to a reevaluation of the alleged association of the swine influenza vaccine and Guillain-Barré syndrome (GBS) as reported by the Centers for Disease Control (CDC),¹ Atlanta, we shall reply on behalf of our coauthors of the publications cited by Alvord.^2-4 He has criticized two relatively minor points and has ignored the major arguments in this series of articles, the principal one being that the CDC accepted as GBS the reported cases obtained by nonclinical health officers and their paramedical assistants, without a systematic review of the medical records by clinical neurologists and frequently without any follow-up information. There is now reason to suspect that many of the CDC cases would not meet reasonable diagnostic criteria for GBS; but whether and how the relative risks as reported by the CDC will be affected awaits the reevaluation in which the CDC . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?